Zobrazeno 1 - 10
of 157
pro vyhledávání: '"Masao Omura"'
Autor:
Kazuki Nakai, Yuya Tsurutani, Koki Irie, Kyoko Teruyama, Sachiko Suematsu, Seishi Matsui, Kohzoh Makita, Jun Saito, Masao Omura, Tetsuo Nishikawa
Publikováno v:
Endocrine Journal, Vol 71, Iss 5, Pp 461-469 (2024)
Plasma aldosterone concentration (PAC) was routinely measured using radioimmunoassay (RIA); however, the RIA kit was discontinued in March 2021 in Japan. This study examined PAC conversion in adrenal venous sampling (AVS) and AVS criteria when measur
Externí odkaz:
https://doaj.org/article/0a6906b18a6d400dbd92576d2eb925d2
Autor:
Sota Oguro, Ryo Morimoto, Kazumasa Seiji, Hideki Ota, Tomo Kinoshita, Masahiro Kawabata, Yoshikiyo Ono, Kei Omata, Yuta Tezuka, Fumitoshi Satoh, Sadayoshi Ito, Nobukazu Moriya, Seishi Matsui, Tetsuo Nishikawa, Masao Omura, Kazuki Nakai, Seishi Nakatsuka, Isao Kurihara, Kazutoshi Miyashita, Wataru Koda, Tetsuya Minami, Yoshiyu Takeda, Mitsuhiro Kometani, Yutaka Oki, Toshihiro Oishi, Takasuke Ushio, Satoshi Goshima, Kei Takase
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Evaluation of feasibility and safety of percutaneous radiofrequency ablation using bipolar radiofrequency devices in a prospective multicenter cohort of patients with benign aldosterone-producing adenoma. A total of five institutions partici
Externí odkaz:
https://doaj.org/article/f8686696e18d4b7db4787d157000a8c9
Autor:
Haremaru Kubo, Yuya Tsurutani, Kosuke Inoue, Kazuki Watanabe, Yuto Yamazaki, Takashi Sunouchi, Yoshitomo Hoshino, Rei Hirose, Sho Katsuragawa, Hiromitsu Tannai, Yukiko Shibahara, Yukio Kakuta, Seishi Matsui, Jun Saito, Masao Omura, Hironobu Sasano, Tetsuo Nishikawa
Publikováno v:
PLoS ONE, Vol 17, Iss 4, p e0267732 (2022)
Primary aldosteronism (PA) usually accompanies suppressed plasma renin activity (PRA) through a negative feedback mechanism. While some cases of PA with unsuppressed PRA were reported, there have been no studies about the characteristics of PA with u
Externí odkaz:
https://doaj.org/article/cb6b2541ded04138b995959c602fca4b
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
The hypothalamus-pituitary-adrenal (HPA) axis plays an important role in primary aldosteronism. Aldosterone biosynthesis is regulated not only by angiotensin II in the renin-angiotensin-aldosterone system, but also by adrenocorticotropic hormone (ACT
Externí odkaz:
https://doaj.org/article/b30fa4e29d2442a2a23bff8d07412177
Autor:
Yuya Tsurutani, MD, PhD, Masao Omura, MD, PhD, Yoko Matsuzawa, MD, PhD, Jun Saito, MD, PhD, Mariko Higa, MD, PhD, Matsuo Taniyama, MD, PhD, Tetsuo Nishikawa, MD, PhD
Publikováno v:
Current Therapeutic Research, Vol 84, Iss C, Pp 26-31 (2017)
Background: Sitagliptin, a dipeptidyl peptidase-4 inhibitor, is widely used in patients with type 2 diabetes. However, the pleiotropic effects of sitagliptin is not well understood. Objective: To assess the clinical efficacy and safety of sitagliptin
Externí odkaz:
https://doaj.org/article/5f4a68c457294d0b82e65ea03b7265a6
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0196526 (2018)
Pentraxin 3 (PTX3) is reported to be a vascular inflammation marker providing prognostic information of vasculopathy. Until today, however, the effect of aldosterone or oxidative stress on the regulation of PTX3 is unknown. In present study, we inves
Externí odkaz:
https://doaj.org/article/1ee04156a1244945870ab68e3d8f83e6
Publikováno v:
Molecules, Vol 18, Iss 12, Pp 15636-15647 (2013)
We examined the ability of aortic smooth muscle cells (AoSMC) prepared from spontaneously diabetic rats to produce aldosterone (Aldo) and the regulatory mechanism that controls their Aldo production. AoSMC of 6 week-old Long-Evans Tokushima Otsuka (L
Externí odkaz:
https://doaj.org/article/72b5a887817f4ee4ae8b30262dbd6fe8
Autor:
Kentaro Sakamoto, Mitsunobu Kawamura, Takahide Kohro, Masao Omura, Takayuki Watanabe, Keiko Ashidate, Toshiyuki Horiuchi, Hidehiko Hara, Nobuo Sekine, Rina Chin, Motoyoshi Tsujino, Toru Hiyoshi, Motoki Tagami, Akira Tanaka, Yasumichi Mori, Takeshi Inazawa, Tsutomu Hirano, Tsutomu Yamazaki, Teruo Shiba, RESEARCH Study Group
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0138332 (2015)
There exists a subpopulation of T2DM in whom first-line doses of statin are insufficient for optimally reducing LDL-C, representing a major risk of CVD. The RESEARCH study focuses on LDL-C reduction in this population along with modifications of the
Externí odkaz:
https://doaj.org/article/f08c265f61aa4a2fb989da8e15025dbf
Autor:
Yusuke Goto, Takumi Kitamoto, Satoki Tanaka, Masafumi Maruo, Sho Sugawara, Kazuto Chiba, Kanetaka Miyazaki, Atsushi Inoue, Kazuki Nakai, Yuya Tsurutani, Jun Saito, Masao Omura, Tetsuo Nishikawa, Tomohiko Ichikawa, Maki Nagata
Publikováno v:
Surgery.
Publikováno v:
Journal of the Endocrine Society. 7
Introduction Hypertension is one of the most common clinical features of patients with overt and subclinical hypercortisolism. Although previous studies have shown the coexistence of autonomous cortisol and aldosterone secretion, it is unclear whethe